IRB #

STUDY00016955

Title

Mobile device-collected actigraphy as a tool for early detection and symptom monitoring in patients with pancreatic cancer

Principal Investigator

Daniel Marks

Study Purpose

Pancreatic Ductal Adenocarcinoma is a difficult disease to detect early. The main purpose of this study is to determine if there is a association between physical activity and PDAC recurrence diagnosis. The secondary purpose to is examine the associations between activity and treatment toxicities.

Medical Condition(s)

Pancreatic Ductal Adenocarcinoma

Eligibility Criteria

- Diagnosis of pancreatic ductal adenocarcinoma within the a 12 month time period prior to enrollment OR Family member or friend with no current diagnosis of malignancy.
- Patients have undergone definitive therapy (surgery and/or radiotherapy.
- No physical or medical limitations that effect mobility.
- No medical conditions that limit physical performance or mobility like heart failure, pulmonary disease, or Parkinson's disease.
- Accelerometer-equipped smartphone (Apple iPhone 5S or newer or Android phones running Google Fit application).
- Not currently pregnant or breastfeeding

Age Range

18 - 99

Healthy Volunteers Needed

Yes

Duration of Participation

This study will last up to 2 years and can require up to 24 visits to OHSU or up to 24 questionnaires given over the phone.

Minors Included

No

Contact

Niko Millington, Study Coordinator, 971-413-9244 or millingt@ohsu.edu

Sponsor

Knight Cancer Institute

Recruitment End

01/01/2020

Compensation Provided

No


Go Back